Angitia Biopharmaceuticals

Healthcare & Life Sciences

Recent Finacing

Series C

Recent Raise

$120M

Angitia Biopharmaceuticals is a clinical-stage biotechnology company developing novel treatments for serious musculoskeletal diseases.